Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients (2015)
- Autores:
- Autores USP: HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; PINTO, GELBA ALMEIDA - HU ; DOREA, EGIDIO LIMA - HU
- Unidades: FCF; HU
- Assuntos: DISLIPIDEMIAS; DOENÇAS METABÓLICAS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 51, suppl. 2, p. 18 res. CPF032, 2015
- Nome do evento: Pharmaceutical Congress of São Paulo
-
ABNT
CASTRO, Paula Ferreira et al. Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 24 abr. 2024. , 2015 -
APA
Castro, P. F., Pinto, G. A., Dórea, E. L., & Hirata, R. D. C. (2015). Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Castro PF, Pinto GA, Dórea EL, Hirata RDC. Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 18 res. CPF032.[citado 2024 abr. 24 ] -
Vancouver
Castro PF, Pinto GA, Dórea EL, Hirata RDC. Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 18 res. CPF032.[citado 2024 abr. 24 ] - Métodos de análise de prescrições potencialmente inadequadas para idosos: estudo comparativo
- Impact of cholesterol-lowering therapies on gene expression of adhesion molecules in mononuclear cells from hypercholesterolemic patients
- Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study
- Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
- Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe
- Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients
- Downregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol
- Síndrome nefrótica
- N-Acetyl-Cysteine improves renal function in chronic kidney disease
- Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
